Biblio
Export 793 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is V [Clear All Filters]
“Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
, “Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
, “Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
, “Heavy Metals Exposure and Alzheimer's Disease and Related Dementias.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1215-1242, 2020.
, “Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 1, pp. 247-257, 2020.
, “Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 3, pp. 897-907, 2020.
, “Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 74, no. 1, pp. 277-286, 2020.
, “Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor.”, J Alzheimers Dis, 2020.
, “Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.”, J Alzheimers Dis, vol. 73, no. 1, pp. 333-345, 2020.
, “Non-Coding RNAs Based Molecular Links in Type 2 Diabetes, Ischemic Stroke, and Vascular Dementia.”, J Alzheimers Dis, vol. 75, no. 2, pp. 353-383, 2020.
, “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
, “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
, “Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 391-405, 2020.
, “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
, “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
, “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
, “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
, “Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.”, J Alzheimers Dis, vol. 72, no. 4, pp. 1269-1277, 2019.
, “Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.”, J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
, “APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke.”, J Alzheimers Dis, vol. 71, no. 1, pp. 245-259, 2019.
, “Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.”, J Alzheimers Dis, vol. 69, no. 1, pp. 91-109, 2019.
, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
, “A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.”, J Alzheimers Dis, vol. 67, no. 1, pp. 181-195, 2019.
,